derivative of monoclonal anti-idiotype antibody Initial experience in treating human lymphoma with a chimeric univalent

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of lymphoid tumors with anti-idiotype antibodies

  2005cited by this paper
• Monoclonal antibody therapy of lymphoid malignancy.

  1985cited by this paper
• Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.

  1985cited by this paper
• A clinical trial of anti-idiotype therapy for B cell malignancy.

  1985cited by this paper
• Activation of complement pathways by univalent antibody derivatives with intact Fc zones.

  1985cited by this paper
• Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response.

  1985cited by this paper
• Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies.

  1985cited by this paper
• The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

  1984cited by this paper
• Therapeutic potential of monovalent monoclonal antibodies

  1984cited by this paper
• Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody.

  1984cited by this paper
• Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.

  1984cited by this paper
• In vivo administration of anti-I-A antibody induces the internalization of B cell surface I-A and I-E without affecting the expression of surface immunoglobulin.

  1984cited by this paper
• Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma.

  1984cited by this paper
• Chimeric univalent antibodies for treating lymphoid malignancies

  1984cited by this paper
• Preparation of F(ab')2 fragments from mouse IgG of various subclasses.

  1983cited by this paper
• Removal of gram-negative endotoxin from solutions by affinity chromatography.

  1983cited by this paper
• Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes.

  1983cited by this paper
• Univalent antibodies kill tumour cells in vitro and in vivo

  1982cited by this paper
• THE KILLING OF LYMPHOMA CELLS BY UNIVALENT DERIVATIVES OF TUMOR-SPECIFIC ANTIBODY11This work was supported by Tenovus, the Cancer Research Campaign, and the Medical Research Council.

  1982cited by this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cited by this paper
• Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.

  1980cited by this paper
• Spontaneous regression of non‐Hodgkin's lymphoma: A report of nine cases

  1980cited by this paper
• Immunoglobulin secretion by mouse X human hybridomas: an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma.

  1980cited by this paper
• Antibody to a molecularly-defined antigen confined to a tumour cell surface

  1975cited by this paper
• Metabolic properties of IgG subclasses in man.

  1970cited by this paper
• Some Aspects of Normal and Abnormal Cell Surface Genetics

  1969cited by this paper
• Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.

  1968cited by this paper
• THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS

  1965cited by this paper

• No citing papers are available for this paper.